クロストリジウムディフィシル分子診断のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Molecular Diagnosis of Clostridium Difficile Market Insights, Forecast to 2028

• レポートコード：QY2207E09842 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のクロストリジウムディフィシル分子診断の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にクロストリジウムディフィシル分子診断の世界市場のxxx％を占める「感度90％以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のクロストリジウムディフィシル分子診断の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのクロストリジウムディフィシル分子診断市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのクロストリジウムディフィシル分子診断市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 クロストリジウムディフィシル分子診断のグローバル主要メーカーには、Roche、Thermo Scientific、Cepheid (Danaher)、BD、Meridian、TECHLAB、Luminex、CerTest Biotec、Quidel、Zhejiang Orient Gene Biotech、Beijing Promed Medical Technology、Jiangsu Besthree Biotechnologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 クロストリジウムディフィシル分子診断市場は、種類と用途によって区分されます。世界のクロストリジウムディフィシル分子診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 感度90％以上、感度90％以下 【用途別セグメント】 病院、診療所、実験室、在宅介護、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - クロストリジウムディフィシル分子診断製品概要 - 種類別市場（感度90％以上、感度90％以下） - 用途別市場（病院、診療所、実験室、在宅介護、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のクロストリジウムディフィシル分子診断販売量予測2017-2028 - 世界のクロストリジウムディフィシル分子診断売上予測2017-2028 - クロストリジウムディフィシル分子診断の地域別販売量 - クロストリジウムディフィシル分子診断の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別クロストリジウムディフィシル分子診断販売量 - 主要メーカー別クロストリジウムディフィシル分子診断売上 - 主要メーカー別クロストリジウムディフィシル分子診断価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（感度90％以上、感度90％以下） - クロストリジウムディフィシル分子診断の種類別販売量 - クロストリジウムディフィシル分子診断の種類別売上 - クロストリジウムディフィシル分子診断の種類別価格 ・用途別市場規模（病院、診療所、実験室、在宅介護、その他） - クロストリジウムディフィシル分子診断の用途別販売量 - クロストリジウムディフィシル分子診断の用途別売上 - クロストリジウムディフィシル分子診断の用途別価格 ・北米市場 - 北米のクロストリジウムディフィシル分子診断市場規模（種類別、用途別） - 主要国別のクロストリジウムディフィシル分子診断市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのクロストリジウムディフィシル分子診断市場規模（種類別、用途別） - 主要国別のクロストリジウムディフィシル分子診断市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のクロストリジウムディフィシル分子診断市場規模（種類別、用途別） - 主要国別のクロストリジウムディフィシル分子診断市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のクロストリジウムディフィシル分子診断市場規模（種類別、用途別） - 主要国別のクロストリジウムディフィシル分子診断市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのクロストリジウムディフィシル分子診断市場規模（種類別、用途別） - 主要国別のクロストリジウムディフィシル分子診断市場規模（トルコ、サウジアラビア） ・企業情報 Roche、Thermo Scientific、Cepheid (Danaher)、BD、Meridian、TECHLAB、Luminex、CerTest Biotec、Quidel、Zhejiang Orient Gene Biotech、Beijing Promed Medical Technology、Jiangsu Besthree Biotechnology ・産業チェーン及び販売チャネル分析 - クロストリジウムディフィシル分子診断の産業チェーン分析 - クロストリジウムディフィシル分子診断の原材料 - クロストリジウムディフィシル分子診断の生産プロセス - クロストリジウムディフィシル分子診断の販売及びマーケティング - クロストリジウムディフィシル分子診断の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - クロストリジウムディフィシル分子診断の産業動向 - クロストリジウムディフィシル分子診断のマーケットドライバー - クロストリジウムディフィシル分子診断の課題 - クロストリジウムディフィシル分子診断の阻害要因 ・主な調査結果

Clostridium difficile infection (CDI) is one of the most important causes of nosocomial diarrhoea and is also becoming important in the community and in populations with low or no risk factors.Especially during outbreaks and during the spread of strains with increased virulence it is important that the laboratory diagnosis is rapid and sensitive to ensure appropriate therapy and quick implementation of hospital hygiene measures.Therefore, the improvement of diagnostic methods is becoming more and more important.
Market Analysis and Insights: Global Molecular Diagnosis of Clostridium Difficile Market
Due to the COVID-19 pandemic, the global Molecular Diagnosis of Clostridium Difficile market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Sensitivity Above 90% accounting for % of the Molecular Diagnosis of Clostridium Difficile global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Molecular Diagnosis of Clostridium Difficile market size is valued at US$ million in 2021, while the US and Europe Molecular Diagnosis of Clostridium Difficile are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Molecular Diagnosis of Clostridium Difficile landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Molecular Diagnosis of Clostridium Difficile include Roche, Thermo Scientific, Cepheid (Danaher), BD, Meridian, TECHLAB, Luminex, CerTest Biotec and Quidel, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Molecular Diagnosis of Clostridium Difficile Scope and Segment
Molecular Diagnosis of Clostridium Difficile market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnosis of Clostridium Difficile market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Sensitivity Above 90%
Sensitivity Below 90%
Segment by Application
Hospital
Clinic
Laboratory
Home Care
Others
By Company
Roche
Thermo Scientific
Cepheid (Danaher)
BD
Meridian
TECHLAB
Luminex
CerTest Biotec
Quidel
Zhejiang Orient Gene Biotech
Beijing Promed Medical Technology
Jiangsu Besthree Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Molecular Diagnosis of Clostridium Difficile Product Introduction
1.2 Market by Type
1.2.1 Global Molecular Diagnosis of Clostridium Difficile Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sensitivity Above 90%
1.2.3 Sensitivity Below 90%
1.3 Market by Application
1.3.1 Global Molecular Diagnosis of Clostridium Difficile Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Home Care
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Molecular Diagnosis of Clostridium Difficile Sales Estimates and Forecasts 2017-2028
2.2 Global Molecular Diagnosis of Clostridium Difficile Revenue Estimates and Forecasts 2017-2028
2.3 Global Molecular Diagnosis of Clostridium Difficile Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Molecular Diagnosis of Clostridium Difficile Sales by Region
2.4.1 Global Molecular Diagnosis of Clostridium Difficile Sales by Region (2017-2022)
2.4.2 Global Sales Molecular Diagnosis of Clostridium Difficile by Region (2023-2028)
2.5 Global Molecular Diagnosis of Clostridium Difficile Revenue by Region
2.5.1 Global Molecular Diagnosis of Clostridium Difficile Revenue by Region (2017-2022)
2.5.2 Global Molecular Diagnosis of Clostridium Difficile Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Molecular Diagnosis of Clostridium Difficile Sales by Manufacturers
3.1.1 Global Top Molecular Diagnosis of Clostridium Difficile Manufacturers by Sales (2017-2022)
3.1.2 Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Molecular Diagnosis of Clostridium Difficile in 2021
3.2 Global Molecular Diagnosis of Clostridium Difficile Revenue by Manufacturers
3.2.1 Global Molecular Diagnosis of Clostridium Difficile Revenue by Manufacturers (2017-2022)
3.2.2 Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Clostridium Difficile Revenue in 2021
3.3 Global Molecular Diagnosis of Clostridium Difficile Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Molecular Diagnosis of Clostridium Difficile Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Molecular Diagnosis of Clostridium Difficile Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Molecular Diagnosis of Clostridium Difficile Sales by Type
4.1.1 Global Molecular Diagnosis of Clostridium Difficile Historical Sales by Type (2017-2022)
4.1.2 Global Molecular Diagnosis of Clostridium Difficile Forecasted Sales by Type (2023-2028)
4.1.3 Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2028)
4.2 Global Molecular Diagnosis of Clostridium Difficile Revenue by Type
4.2.1 Global Molecular Diagnosis of Clostridium Difficile Historical Revenue by Type (2017-2022)
4.2.2 Global Molecular Diagnosis of Clostridium Difficile Forecasted Revenue by Type (2023-2028)
4.2.3 Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Type (2017-2028)
4.3 Global Molecular Diagnosis of Clostridium Difficile Price by Type
4.3.1 Global Molecular Diagnosis of Clostridium Difficile Price by Type (2017-2022)
4.3.2 Global Molecular Diagnosis of Clostridium Difficile Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Molecular Diagnosis of Clostridium Difficile Sales by Application
5.1.1 Global Molecular Diagnosis of Clostridium Difficile Historical Sales by Application (2017-2022)
5.1.2 Global Molecular Diagnosis of Clostridium Difficile Forecasted Sales by Application (2023-2028)
5.1.3 Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2028)
5.2 Global Molecular Diagnosis of Clostridium Difficile Revenue by Application
5.2.1 Global Molecular Diagnosis of Clostridium Difficile Historical Revenue by Application (2017-2022)
5.2.2 Global Molecular Diagnosis of Clostridium Difficile Forecasted Revenue by Application (2023-2028)
5.2.3 Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Application (2017-2028)
5.3 Global Molecular Diagnosis of Clostridium Difficile Price by Application
5.3.1 Global Molecular Diagnosis of Clostridium Difficile Price by Application (2017-2022)
5.3.2 Global Molecular Diagnosis of Clostridium Difficile Price Forecast by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnosis of Clostridium Difficile Market Size by Type
6.1.1 North America Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2028)
6.1.2 North America Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2028)
6.2 North America Molecular Diagnosis of Clostridium Difficile Market Size by Application
6.2.1 North America Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2028)
6.2.2 North America Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2028)
6.3 North America Molecular Diagnosis of Clostridium Difficile Market Size by Country
6.3.1 North America Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2028)
6.3.2 North America Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Molecular Diagnosis of Clostridium Difficile Market Size by Type
7.1.1 Europe Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2028)
7.1.2 Europe Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2028)
7.2 Europe Molecular Diagnosis of Clostridium Difficile Market Size by Application
7.2.1 Europe Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2028)
7.2.2 Europe Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2028)
7.3 Europe Molecular Diagnosis of Clostridium Difficile Market Size by Country
7.3.1 Europe Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2028)
7.3.2 Europe Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Molecular Diagnosis of Clostridium Difficile Market Size by Type
8.1.1 Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2028)
8.1.2 Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2028)
8.2 Asia Pacific Molecular Diagnosis of Clostridium Difficile Market Size by Application
8.2.1 Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2028)
8.2.2 Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2028)
8.3 Asia Pacific Molecular Diagnosis of Clostridium Difficile Market Size by Region
8.3.1 Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales by Region (2017-2028)
8.3.2 Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Molecular Diagnosis of Clostridium Difficile Market Size by Type
9.1.1 Latin America Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2028)
9.1.2 Latin America Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2028)
9.2 Latin America Molecular Diagnosis of Clostridium Difficile Market Size by Application
9.2.1 Latin America Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2028)
9.2.2 Latin America Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2028)
9.3 Latin America Molecular Diagnosis of Clostridium Difficile Market Size by Country
9.3.1 Latin America Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2028)
9.3.2 Latin America Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Market Size by Type
10.1.1 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2028)
10.1.2 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2028)
10.2 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Market Size by Application
10.2.1 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2028)
10.2.2 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2028)
10.3 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Market Size by Country
10.3.1 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2028)
10.3.2 Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Thermo Scientific
11.2.1 Thermo Scientific Corporation Information
11.2.2 Thermo Scientific Overview
11.2.3 Thermo Scientific Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Thermo Scientific Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Scientific Recent Developments
11.3 Cepheid (Danaher)
11.3.1 Cepheid (Danaher) Corporation Information
11.3.2 Cepheid (Danaher) Overview
11.3.3 Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cepheid (Danaher) Recent Developments
11.4 BD
11.4.1 BD Corporation Information
11.4.2 BD Overview
11.4.3 BD Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BD Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BD Recent Developments
11.5 Meridian
11.5.1 Meridian Corporation Information
11.5.2 Meridian Overview
11.5.3 Meridian Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Meridian Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Meridian Recent Developments
11.6 TECHLAB
11.6.1 TECHLAB Corporation Information
11.6.2 TECHLAB Overview
11.6.3 TECHLAB Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 TECHLAB Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 TECHLAB Recent Developments
11.7 Luminex
11.7.1 Luminex Corporation Information
11.7.2 Luminex Overview
11.7.3 Luminex Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Luminex Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Luminex Recent Developments
11.8 CerTest Biotec
11.8.1 CerTest Biotec Corporation Information
11.8.2 CerTest Biotec Overview
11.8.3 CerTest Biotec Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CerTest Biotec Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CerTest Biotec Recent Developments
11.9 Quidel
11.9.1 Quidel Corporation Information
11.9.2 Quidel Overview
11.9.3 Quidel Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Quidel Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Quidel Recent Developments
11.10 Zhejiang Orient Gene Biotech
11.10.1 Zhejiang Orient Gene Biotech Corporation Information
11.10.2 Zhejiang Orient Gene Biotech Overview
11.10.3 Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zhejiang Orient Gene Biotech Recent Developments
11.11 Beijing Promed Medical Technology
11.11.1 Beijing Promed Medical Technology Corporation Information
11.11.2 Beijing Promed Medical Technology Overview
11.11.3 Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Beijing Promed Medical Technology Recent Developments
11.12 Jiangsu Besthree Biotechnology
11.12.1 Jiangsu Besthree Biotechnology Corporation Information
11.12.2 Jiangsu Besthree Biotechnology Overview
11.12.3 Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jiangsu Besthree Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Molecular Diagnosis of Clostridium Difficile Industry Chain Analysis
12.2 Molecular Diagnosis of Clostridium Difficile Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Molecular Diagnosis of Clostridium Difficile Production Mode & Process
12.4 Molecular Diagnosis of Clostridium Difficile Sales and Marketing
12.4.1 Molecular Diagnosis of Clostridium Difficile Sales Channels
12.4.2 Molecular Diagnosis of Clostridium Difficile Distributors
12.5 Molecular Diagnosis of Clostridium Difficile Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Molecular Diagnosis of Clostridium Difficile Industry Trends
13.2 Molecular Diagnosis of Clostridium Difficile Market Drivers
13.3 Molecular Diagnosis of Clostridium Difficile Market Challenges
13.4 Molecular Diagnosis of Clostridium Difficile Market Restraints
14 Key Findings in The Global Molecular Diagnosis of Clostridium Difficile Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Molecular Diagnosis of Clostridium Difficile Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Sensitivity Above 90%
Table 3. Major Manufacturers of Sensitivity Below 90%
Table 4. Global Molecular Diagnosis of Clostridium Difficile Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Molecular Diagnosis of Clostridium Difficile Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Molecular Diagnosis of Clostridium Difficile Sales by Region (2017-2022) & (K Units)
Table 7. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Region (2017-2022)
Table 8. Global Molecular Diagnosis of Clostridium Difficile Sales by Region (2023-2028) & (K Units)
Table 9. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Region (2023-2028)
Table 10. Global Molecular Diagnosis of Clostridium Difficile Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Region (2017-2022)
Table 12. Global Molecular Diagnosis of Clostridium Difficile Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Region (2023-2028)
Table 14. Global Molecular Diagnosis of Clostridium Difficile Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Molecular Diagnosis of Clostridium Difficile Sales Share by Manufacturers (2017-2022)
Table 16. Global Molecular Diagnosis of Clostridium Difficile Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Molecular Diagnosis of Clostridium Difficile Revenue Share by Manufacturers (2017-2022)
Table 18. Molecular Diagnosis of Clostridium Difficile Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Molecular Diagnosis of Clostridium Difficile Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Molecular Diagnosis of Clostridium Difficile by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis of Clostridium Difficile as of 2021)
Table 21. Molecular Diagnosis of Clostridium Difficile Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Molecular Diagnosis of Clostridium Difficile Product Offered
Table 23. Date of Manufacturers Enter into Molecular Diagnosis of Clostridium Difficile Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 26. Global Molecular Diagnosis of Clostridium Difficile Sales by Type (2023-2028) & (K Units)
Table 27. Global Molecular Diagnosis of Clostridium Difficile Sales Share by Type (2017-2022)
Table 28. Global Molecular Diagnosis of Clostridium Difficile Sales Share by Type (2023-2028)
Table 29. Global Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Molecular Diagnosis of Clostridium Difficile Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Molecular Diagnosis of Clostridium Difficile Revenue Share by Type (2017-2022)
Table 32. Global Molecular Diagnosis of Clostridium Difficile Revenue Share by Type (2023-2028)
Table 33. Molecular Diagnosis of Clostridium Difficile Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Molecular Diagnosis of Clostridium Difficile Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 36. Global Molecular Diagnosis of Clostridium Difficile Sales by Application (2023-2028) & (K Units)
Table 37. Global Molecular Diagnosis of Clostridium Difficile Sales Share by Application (2017-2022)
Table 38. Global Molecular Diagnosis of Clostridium Difficile Sales Share by Application (2023-2028)
Table 39. Global Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Molecular Diagnosis of Clostridium Difficile Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Molecular Diagnosis of Clostridium Difficile Revenue Share by Application (2017-2022)
Table 42. Global Molecular Diagnosis of Clostridium Difficile Revenue Share by Application (2023-2028)
Table 43. Molecular Diagnosis of Clostridium Difficile Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Molecular Diagnosis of Clostridium Difficile Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 46. North America Molecular Diagnosis of Clostridium Difficile Sales by Type (2023-2028) & (K Units)
Table 47. North America Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Molecular Diagnosis of Clostridium Difficile Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 50. North America Molecular Diagnosis of Clostridium Difficile Sales by Application (2023-2028) & (K Units)
Table 51. North America Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Molecular Diagnosis of Clostridium Difficile Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022) & (K Units)
Table 54. North America Molecular Diagnosis of Clostridium Difficile Sales by Country (2023-2028) & (K Units)
Table 55. North America Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Molecular Diagnosis of Clostridium Difficile Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 58. Europe Molecular Diagnosis of Clostridium Difficile Sales by Type (2023-2028) & (K Units)
Table 59. Europe Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Molecular Diagnosis of Clostridium Difficile Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 62. Europe Molecular Diagnosis of Clostridium Difficile Sales by Application (2023-2028) & (K Units)
Table 63. Europe Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Molecular Diagnosis of Clostridium Difficile Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022) & (K Units)
Table 66. Europe Molecular Diagnosis of Clostridium Difficile Sales by Country (2023-2028) & (K Units)
Table 67. Europe Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Molecular Diagnosis of Clostridium Difficile Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Molecular Diagnosis of Clostridium Difficile Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Molecular Diagnosis of Clostridium Difficile Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Molecular Diagnosis of Clostridium Difficile Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Molecular Diagnosis of Clostridium Difficile Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Molecular Diagnosis of Clostridium Difficile Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Molecular Diagnosis of Clostridium Difficile Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue by Country (2023-2028) & (US$ Million)
Table 105. Roche Corporation Information
Table 106. Roche Description and Major Businesses
Table 107. Roche Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Roche Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Roche Recent Developments
Table 110. Thermo Scientific Corporation Information
Table 111. Thermo Scientific Description and Major Businesses
Table 112. Thermo Scientific Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Thermo Scientific Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Thermo Scientific Recent Developments
Table 115. Cepheid (Danaher) Corporation Information
Table 116. Cepheid (Danaher) Description and Major Businesses
Table 117. Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Cepheid (Danaher) Recent Developments
Table 120. BD Corporation Information
Table 121. BD Description and Major Businesses
Table 122. BD Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. BD Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. BD Recent Developments
Table 125. Meridian Corporation Information
Table 126. Meridian Description and Major Businesses
Table 127. Meridian Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Meridian Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Meridian Recent Developments
Table 130. TECHLAB Corporation Information
Table 131. TECHLAB Description and Major Businesses
Table 132. TECHLAB Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. TECHLAB Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. TECHLAB Recent Developments
Table 135. Luminex Corporation Information
Table 136. Luminex Description and Major Businesses
Table 137. Luminex Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Luminex Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Luminex Recent Developments
Table 140. CerTest Biotec Corporation Information
Table 141. CerTest Biotec Description and Major Businesses
Table 142. CerTest Biotec Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. CerTest Biotec Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. CerTest Biotec Recent Developments
Table 145. Quidel Corporation Information
Table 146. Quidel Description and Major Businesses
Table 147. Quidel Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Quidel Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Quidel Recent Developments
Table 150. Zhejiang Orient Gene Biotech Corporation Information
Table 151. Zhejiang Orient Gene Biotech Description and Major Businesses
Table 152. Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Zhejiang Orient Gene Biotech Recent Developments
Table 155. Beijing Promed Medical Technology Corporation Information
Table 156. Beijing Promed Medical Technology Description and Major Businesses
Table 157. Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Beijing Promed Medical Technology Recent Developments
Table 160. Jiangsu Besthree Biotechnology Corporation Information
Table 161. Jiangsu Besthree Biotechnology Description and Major Businesses
Table 162. Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Jiangsu Besthree Biotechnology Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Molecular Diagnosis of Clostridium Difficile Distributors List
Table 168. Molecular Diagnosis of Clostridium Difficile Customers List
Table 169. Molecular Diagnosis of Clostridium Difficile Market Trends
Table 170. Molecular Diagnosis of Clostridium Difficile Market Drivers
Table 171. Molecular Diagnosis of Clostridium Difficile Market Challenges
Table 172. Molecular Diagnosis of Clostridium Difficile Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Molecular Diagnosis of Clostridium Difficile Product Picture
Figure 3. Global Molecular Diagnosis of Clostridium Difficile Market Share by Type in 2021 & 2028
Figure 3. Sensitivity Above 90% Product Picture
Figure 4. Sensitivity Below 90% Product Picture
Figure 5. Global Molecular Diagnosis of Clostridium Difficile Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Laboratory
Figure 9. Home Care
Figure 10. Others
Figure 11. Molecular Diagnosis of Clostridium Difficile Report Years Considered
Figure 12. Global Molecular Diagnosis of Clostridium Difficile Sales 2017-2028 (K Units)
Figure 13. Global Molecular Diagnosis of Clostridium Difficile Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Molecular Diagnosis of Clostridium Difficile Revenue 2017-2028 (US$ Million)
Figure 15. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Region (2017-2022)
Figure 17. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Region (2023-2028)
Figure 18. North America Molecular Diagnosis of Clostridium Difficile Sales YoY (2017-2028) & (K Units)
Figure 19. North America Molecular Diagnosis of Clostridium Difficile Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Molecular Diagnosis of Clostridium Difficile Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Molecular Diagnosis of Clostridium Difficile Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Molecular Diagnosis of Clostridium Difficile Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Molecular Diagnosis of Clostridium Difficile Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Molecular Diagnosis of Clostridium Difficile Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Molecular Diagnosis of Clostridium Difficile Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Molecular Diagnosis of Clostridium Difficile Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Molecular Diagnosis of Clostridium Difficile Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Molecular Diagnosis of Clostridium Difficile in the World: Market Share by Molecular Diagnosis of Clostridium Difficile Revenue in 2021
Figure 30. Global Molecular Diagnosis of Clostridium Difficile Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2028)
Figure 32. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Type (2017-2028)
Figure 33. Global Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2028)
Figure 34. Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Application (2017-2028)
Figure 35. North America Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2028)
Figure 36. North America Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Type (2017-2028)
Figure 37. North America Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2028)
Figure 38. North America Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Application (2017-2028)
Figure 39. North America Molecular Diagnosis of Clostridium Difficile Sales Share by Country (2017-2028)
Figure 40. North America Molecular Diagnosis of Clostridium Difficile Revenue Share by Country (2017-2028)
Figure 41. United States Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2028)
Figure 44. Europe Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Type (2017-2028)
Figure 45. Europe Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2028)
Figure 46. Europe Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Application (2017-2028)
Figure 47. Europe Molecular Diagnosis of Clostridium Difficile Sales Share by Country (2017-2028)
Figure 48. Europe Molecular Diagnosis of Clostridium Difficile Revenue Share by Country (2017-2028)
Figure 49. Germany Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 50. France Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Molecular Diagnosis of Clostridium Difficile Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Molecular Diagnosis of Clostridium Difficile Revenue Share by Region (2017-2028)
Figure 60. China Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 63. India Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2028)
Figure 70. Latin America Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2028)
Figure 72. Latin America Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Molecular Diagnosis of Clostridium Difficile Sales Share by Country (2017-2028)
Figure 74. Latin America Molecular Diagnosis of Clostridium Difficile Revenue Share by Country (2017-2028)
Figure 75. Mexico Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Molecular Diagnosis of Clostridium Difficile Revenue Share by Country (2017-2028)
Figure 84. Turkey Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Molecular Diagnosis of Clostridium Difficile Revenue (2017-2028) & (US$ Million)
Figure 87. Molecular Diagnosis of Clostridium Difficile Value Chain
Figure 88. Molecular Diagnosis of Clostridium Difficile Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

---